Skip to main content

Table 1 Clinical characteristics of patients with mucin-produced tumors

From: Mucin-producing tumors of the ovary——preoperative differentiation between metastatic ovarian mucinous carcinoma and primary mucinous malignant tumors

Variables

PMOT

MOMC

p

Age(year), median (25th percentile and 75th percentile)

52(31, 66)

49(38, 56)

0.152

HE4 (U/mL), median (25th percentile and 75th percentile)

60.6(44.2, 85.0)

57.3(52, 88.8)

0.717

CA125(U/mL), median (25th percentile and 75th percentile)

41.6(22.4, 84.5)

30.9(17.3, 67.45)

0.447

CA199(U/mL), median (25th percentile and 75th percentile)

27(13.5, 246)

37.7(13.8, 220)

0.837

CEA(5U/mL), median (25th percentile and 75th percentile)

1.8(1.3, 2.9)

5.5(2.9, 14.2)

0.002

The primary malignant tumor history (Y/N)

22/0

14/25

0.000

FIGO

22

39

-

I

20

\

 

II

0

\

 

III

1

\

 

IV

1

39

 
  1. POMT Primary ovarian mucinous malignant tumor, MOMC Metastatic ovarian mucinous carcinoma, HE4 Human epididymis 4, CA125 Cancer antigen 125, CA199 Cancer antigen 199, CEA carcinoembryonic antigen